Paper Details

  1. Home
  2. Paper Details

Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses.

Author: KangS, TaylorJ R, TschenE, WolfJ E

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This study aimed to further explore the therapeutic potential of 3% diclofenac in 2.5% hyaluronan gel for the treatment of actinic keratosis.
Paper Details　
Original Abstract of the Article :
Actinic keratoses (AKs) are epidermal skin lesions with the potential to develop into invasive squamous cell carcinoma (SCC). Treatment at an early stage may prevent development of SCC. Current treatment options are highly destructive and associated with significant side-effects. Early studies with ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1046/j.1365-4362.2001.01324.x

データ提供：米国国立医学図書館（NLM）

Topical Diclofenac: A New Hope for Actinic Keratoses

Actinic keratoses (AKs), precancerous skin lesions, are a common concern, often leading to invasive squamous cell carcinoma. Current treatment options for AKs can be harsh and associated with significant side effects. This study explores the therapeutic potential of topical diclofenac in 2.5% hyaluronan gel as a less invasive and more tolerable alternative. The researchers build upon previous findings demonstrating the effectiveness and good tolerability of this gel, aiming to further evaluate its efficacy in treating AKs. It's like discovering a new oasis in the vast desert of dermatological treatments, offering a refreshing alternative to traditional approaches.

Topical Diclofenac: A Gentle Approach to Skin Cancer Prevention

This research suggests that topical diclofenac in 2.5% hyaluronan gel could be a promising treatment option for AKs. Its effectiveness and good tolerability make it a valuable alternative to more invasive methods, potentially reducing the risk of complications and improving patient experience. This discovery is like finding a hidden spring in the desert, providing a source of relief and hope for individuals facing the threat of skin cancer.

Protecting Your Skin: Sun Safety and Early Intervention

This study highlights the importance of early intervention in treating AKs, emphasizing the potential of topical diclofenac as an effective and well-tolerated treatment option. It serves as a reminder to prioritize sun safety and seek professional evaluation for any suspicious skin lesions. Protecting your skin from the sun's harmful rays is crucial, like guarding a precious oasis from the scorching desert sun.

Dr.Camel's Conclusion

The search for effective and tolerable treatments for AKs is a continuous journey, much like a camel traversing a vast desert. This research reveals a promising oasis in the form of topical diclofenac, offering a gentler approach to skin cancer prevention. This discovery underscores the importance of ongoing research and development in dermatology, bringing us closer to a future where skin cancer is effectively prevented and treated.

Date :
  1. Date Completed 2002-01-23
  2. Date Revised 2019-07-22
Further Info :

Pubmed ID

11737438

DOI: Digital Object Identifier

10.1046/j.1365-4362.2001.01324.x

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.